Gregory Berk Gt Biopharma, Inc. (GTBP) insider trading activity

GTBP Quotes by TradingView

Gregory Berk is Pres. of R&D, CMO of GT Biopharma, Inc.. Currently has a direct ownership of 278,058 shares of GTBP, which is worth approximately $606,166. The most recent transaction as insider was on Feb 16, 2021, when has been sold 278,058 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 278K
0% 3M change
0% 12M change
Total Value Held $606,166

Gregory Berk Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 16 2021
BUY
Grant, award, or other acquisition
-
278,058 Added 50.0%
278,058 Common Stock
GB

Gregory Berk

Pres. of R&D, CMO
Brisbane, CA

Track Institutional and Insider Activities on GTBP

Follow GT Biopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GTBP shares.

Notify only if

Insider Trading

Get notified when an Gt Biopharma, Inc. insider buys or sells GTBP shares.

Notify only if

News

Receive news related to GT Biopharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GTBP